Trials / Conditions / Prodromal Alzheimer's Disease

Prodromal Alzheimer's Disease

23 registered clinical trials studyying Prodromal Alzheimer's Disease — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Alzheimer's Tau Platform: Master Protocol NCT06957418	Paul S. Aisen	Phase 2
Not Yet Recruiting	Alzheimer's Tau Platform: Regimen A - AADvac1 NCT07167966	Paul S. Aisen	Phase 2
Withdrawn	Clinical Trial of AGB101 for Mild Cognitive Impairment NCT05986721	AgeneBio	Phase 2
Enrolling By Invitation	Combined tDCS and Cognitive Training in Alzheimer's NCT06861231	University of Valencia	N/A
Completed	Financial Incentives and Recruitment to the APT Webstudy NCT06033066	University of Southern California	N/A
Recruiting	COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot St NCT06105320	Karolinska University Hospital	N/A
Recruiting	Exploring the Gut-Brain Axis in Ageing and Neurodegeneration NCT05934188	IRCCS San Camillo, Venezia, Italy	—
Recruiting	A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) NCT05462106	AC Immune SA	Phase 1 / Phase 2
Unknown	Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease NCT05349318	Assaf-Harofeh Medical Center	N/A
Unknown	Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study NCT04992975	Nottingham University Hospitals NHS Trust	—
Completed	Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping NCT04928976	Novoic Limited	—
Unknown	Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension NCT04937959	Novoic Limited	—
Terminated	Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension NCT04951284	Novoic Limited	—
Unknown	Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - PAST E NCT04851496	Novoic Limited	—
Terminated	Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE NCT04846426	Novoic Limited	—
Completed	Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech NCT04828122	Novoic Limited	—
Enrolling By Invitation	The Digital Memory Notebook NCT04240665	University of California, Davis	N/A
Recruiting	Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease NCT04029623	Emory University	N/A
Completed	TRC-PAD Program: In-Clinic Trial-Ready Cohort NCT04004767	University of Southern California	—
Completed	Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease NCT03486938	AgeneBio	Phase 2 / Phase 3
Completed	Deferiprone to Delay Dementia (The 3D Study) NCT03234686	Neuroscience Trials Australia	Phase 2
Completed	An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-893 NCT02910739	Merck Sharp & Dohme LLC	Phase 1
Terminated	Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-893 NCT01953601	Merck Sharp & Dohme LLC	Phase 3